The Major Histocompatibility Complex of Genes

Similar documents
The Major Histocompatibility Complex (MHC)

Antigen Presentation to T lymphocytes

Significance of the MHC

HLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol

Significance of the MHC

the HLA complex Hanna Mustaniemi,

Historical definition of Antigen. An antigen is a foreign substance that elicits the production of antibodies that specifically binds to the antigen.

HLA and antigen presentation. Department of Immunology Charles University, 2nd Medical School University Hospital Motol

Significance of the MHC

The major histocompatibility complex (MHC) is a group of genes that governs tumor and tissue transplantation between individuals of a species.

The Major Histocompatibility Complex

The Major Histocompatibility Complex (MHC)

Major Histocompatibility Complex (MHC) and T Cell Receptors

Basic Immunology. Lecture 5 th and 6 th Recognition by MHC. Antigen presentation and MHC restriction

MHC class I MHC class II Structure of MHC antigens:

Completing the CIBMTR Confirmation of HLA Typing Form (Form 2005)

General information. Cell mediated immunity. 455 LSA, Tuesday 11 to noon. Anytime after class.

Antigen Recognition by T cells

Profiling HLA motifs by large scale peptide sequencing Agilent Innovators Tour David K. Crockett ARUP Laboratories February 10, 2009

Two categories of immune response. immune response. infection. (adaptive) Later immune response. immune response

B F. Location of MHC class I pockets termed B and F that bind P2 and P9 amino acid side chains of the peptide

Class I Ag processing. TAP= transporters associated with antigen processing Transport peptides into ER

T-cell receptor feature. Antibody/antigen interaction. Major Histocompatibility Complex. Antigen processing. Antigen presentation

Key Concept B F. How do peptides get loaded onto the proper kind of MHC molecule?

Human immune system. CH Chen

Dr. Yi-chi M. Kong August 8, 2001 Benjamini. Ch. 19, Pgs Page 1 of 10 TRANSPLANTATION

The MHC and Transplantation Brendan Clark. Transplant Immunology, St James s University Hospital, Leeds, UK

T Cell Development. Xuefang Cao, MD, PhD. November 3, 2015

AG MHC HLA APC Ii EPR TAP ABC CLIP TCR

Principles of Adaptive Immunity

Helminth worm, Schistosomiasis Trypanosomes, sleeping sickness Pneumocystis carinii. Ringworm fungus HIV Influenza

Antigen Presentation to T lymphocytes

Transplantation. Immunology Unit College of Medicine King Saud University

How T cells recognize antigen. How T cells recognize antigen -concepts

Alleles: the alternative forms of a gene found in different individuals. Allotypes or allomorphs: the different protein forms encoded by alleles

Immunology - Lecture 2 Adaptive Immune System 1

[Some people are Rh positive and some are Rh negative whether they have the D antigen on the surface of their cells or not].

Test Bank for Basic Immunology Functions and Disorders of the Immune System 4th Edition by Abbas

Nomenclature. HLA genetics in transplantation. HLA genetics in autoimmunity

CELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM.

Human Leukocyte Antigens and donor selection

Structure and Function of Antigen Recognition Molecules

Antigen processing and presentation. Monika Raulf

Histocompatibility antigens

LESSON 2: THE ADAPTIVE IMMUNITY

Andrea s SI Session PCB Practice Test Test 3

The Human Major Histocompatibility Complex

Chapter 6. Antigen Presentation to T lymphocytes

Antigen capture and presentation to T lymphocytes

Basel - 6 September J.-M. Tiercy National Reference Laboratory for Histocompatibility (LNRH) University Hospital Geneva

HLA and more. Ilias I.N. Doxiadis. Geneva 03/04/2012.

Adaptive Immune System

The Immune System. These are classified as the Innate and Adaptive Immune Responses. Innate Immunity

Immunology Lecture 4. Clinical Relevance of the Immune System

Antigen Receptor Structures October 14, Ram Savan

The role of HLA in Allogeneic Hematopoietic Stem Cell Transplantation and Platelet Refractoriness.

SINGLE CHOICE. 5. The gamma invariant chain binds to this molecule during its intracytoplasmic transport. A TCR B BCR C MHC II D MHC I E FcγR

White Blood Cells (WBCs)

25/10/2017. Clinical Relevance of the HLA System in Blood Transfusion. Outline of talk. Major Histocompatibility Complex

Antigen Presentation and T Lymphocyte Activation. Abul K. Abbas UCSF. FOCiS

T Cell Development II: Positive and Negative Selection

10/18/2012. A primer in HLA: The who, what, how and why. What?

Introduction to Immunology Part 2 September 30, Dan Stetson

Robert B. Colvin, M.D. Department of Pathology Massachusetts General Hospital Harvard Medical School

BDC Keystone Genetics Type 1 Diabetes. Immunology of diabetes book with Teaching Slides

Autoimmunity. Autoimmunity arises because of defects in central or peripheral tolerance of lymphocytes to selfantigens

The Adaptive Immune Response: T lymphocytes and Their Functional Types *

Lecture 6. Burr BIO 4353/6345 HIV/AIDS. Tetramer staining of T cells (CTL s) Andrew McMichael seminar: Background

IMMUNOGENETICS AND TRANSPLANTATION

Phase of immune response

MATCHMAKER, MATCHMAKER, MAKE ME A MATCH, FIND ME A MISMATCHED TRANSPLANT TO CATCH

1. Overview of Adaptive Immunity

Indian Journal of Nephrology Indian J Nephrol 2001;11: 88-97

T Cell Differentiation

Antigen presenting cells

Generation of antibody diversity October 18, Ram Savan

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:

T-cell activation T cells migrate to secondary lymphoid tissues where they interact with antigen, antigen-presenting cells, and other lymphocytes:

T cell development October 28, Dan Stetson

IMMUNE CELL SURFACE RECEPTORS AND THEIR FUNCTIONS

Lecture 11. Immunology and disease: parasite antigenic diversity

Beta Thalassemia Case Study Introduction to Bioinformatics

Detection of 549 new HLA alleles in potential stem cell donors from the United States, Poland and Germany

Tumors arise from accumulated genetic mutations. Tumor Immunology (Cancer)

all of the above the ability to impart long term memory adaptive immunity all of the above bone marrow none of the above

Immunology 2011 Lecture 11 Innate Immunity & Genetics of Inbreeding. 6 October

HLA and disease association

TCR, MHC and coreceptors

IMMUNOLOGY. Elementary Knowledge of Major Histocompatibility Complex and HLA Typing

IMMUNOGENETICS AND INTRODUCTION TO TRANSPLANTATION

Clinical Relevance of the HLA System in Blood Transfusion. Dr Colin J Brown PhD FRCPath. October 2017

Cell Biology from an Immune Perspective

Immunology. Teamwork 437. Lecture (3): Cell Mediated Immunity. Color index: IMPORTANT Definition Explanations + notes Extra (or gray)

RAISON D ETRE OF THE IMMUNE SYSTEM:

The Innate Immune Response

Immunity and Cancer. Doriana Fruci. Lab di Immuno-Oncologia

The Adaptive Immune Response. T-cells

Chapter 22: The Lymphatic System and Immunity

Autoimmunity & Transplantation. Dr. Aws Alshamsan Department of Pharmaceu5cs Office: AA87 Tel:

a) The statement is true for X = 400, but false for X = 300; b) The statement is true for X = 300, but false for X = 200;

Transcription:

The Major Histocompatibility Complex of Genes

Topic 4 The Major Histocompatibility Complex Outline of Lectures The immunological reasons for transplant rejection How the MHC was discovered using inbred strains of mice That T cells recognise MHC molecules What is meant by the term Antigen Presentation The structure function relationships of MHC molecules The principles of the interactions between peptide antigens and MHC molecules The structure and organisation of human and mouse MHC loci The meaning of polymorphism and polygenism in the MHC

Transplant rejection Early attempts to transplant tissues failed Rejection of transplanted tissue was associated with inflammation and lymphocyte infiltration IMMUNE GRAFT REJECTION http://www-medlib.med.utah.edu/webpath/jpeg5/cv171 http://tpis.upmc.edu/tpis/images/c00005c

The origin of Immunogenetics

Genetic basis of transplant rejection Inbred mouse strains - all genes are identical Transplantation of skin between strains showed that rejection or acceptance was dependent upon the genetics of each strain ACCEPTED Skin from an inbred mouse grafted onto the same strain of mouse REJECTED Skin from an inbred mouse grafted onto a different strain of mouse

Immunological basis of graft rejection Primary rejection of strain skin e.g. 10 days Transfer lymphocytes from primed mouse Lyc 6 months Naïve mouse Secondary rejection of strain skin e.g. 3 days Primary rejection of strain skin e.g. 10 days Transplant rejection is due to an antigen-specific immune response with immunological memory.

Immunogenetics of graft rejection Parental strains A X B F1 hybrid (one set of alleles from each parent) A x B A x B ACCEPTED A REJECTED Mice of strain (A x B) are immunologically tolerant to A or B skin Skin from (A x B) mice carry antigens that are recognised as foreign by parental strains B

Major Histocompatibility Complex MHC In mice the MHC is called H-2 Rapid graft rejection between strains segregated with Antigen-2, encoded as part of the MHC haplotype (A set of linked genes inherited as a unit) Inbred mice identical at H-2 did not reject skin grafts from each other MHC genetics in mice is simplified by inbred strains In humans the MHC is called the Human Leukocyte Antigen system HLA Only monozygous twins are identical at the HLA locus The human population is extensively out bred MHC genetics in humans is extremely complex

T cells respond to MHC antigens Graft rejection in vivo is mediated by infiltrating T lymphocytes The in-vitro correlate of graft rejection is the MIXED LYMPHOCYTE REACTION Responder cells from an MHC-A mouse T + Irradiated stimulator cells from an MHC-A mouse T cells do not respond T Responder cells from an MHC-A mouse T + Irradiated stimulator cells from an MHC-B mouse T cells respond T T T T T T T MHC antigens are involved in the activation of T cells

MHC directs the response of T cells to foreign antigens Graft rejection is an unnatural immune response MHC antigens PRESENT foreign antigens to T cells Cells that present antigen are ANTIGEN PRESENTING CELLS T Y Ag T Y TYY T T Y Y T Blocking anti-mhc antibody Y Y Y T Y Ag Anti response No anti response

Antigen recognition by T cells requires peptide antigens and presenting cells that express MHC molecules YT Soluble native Ag Cell surface native Ag Soluble peptides of Ag Cell surface peptides of Ag Cell surface peptides of Ag presented by cells that express MHC antigens No T cell response No T cell response No T cell response No T cell response T cell response

MHC molecules MHC class I Peptide MHC class II Peptide binding groove Cell Membrane

Differential distribution of MHC molecules Tissue MHC class I MHC class II T cells +++ +/- B cells +++ +++ Macrophages +++ ++ Other APC +++ +++ Thymus epithelium + +++ Neutrophils +++ - Hepatocytes + - Kidney + - Brain + - Erythrocytes - - Cell activation affects the level of MHC expression. The pattern of expression reflects the function of MHC molecules: Class I is involved in the regulation of anti-viral immune responses Class II involved in regulation of the cells of the immune system Anucleate erythrocytes can not support virus replication - hence no MHC class I. Some pathogens exploit this - e.g. Plasmodium species.

Overall structure of MHC class I molecules MHC-encoded a-chain of 43kDa a2 a3 a1 b2m a-chain anchored to the cell membrane Peptide antigen in a groove formed from a pair of a-helicies on a floor of anti-parallel b strands b2-microglobulin, 12kDa, non-mhc encoded, non-transmembrane, non covalently bound to a- chain a3 domain & b2m have structural & amino acid sequence homology with Ig C domains Ig GENE SUPERFAMILY

MHC class I molecule structure Peptide a-chain b2-microglobulin Chains Structures

Structure of MHC class I molecules a1 and a2 domains form two segmented a-helices on eight anti-parallel b-strands to form an antigen-binding cleft. Chains Structures Properties of the inner faces of the helices and floor of the cleft determine which peptides bind to the MHC molecule

View structures

Overall structure of MHC class II molecules MHC-encoded, a-chain of 34kDa and a b-chain of 29kDa b1 b2 a1 a2 a and b chains anchored to the cell membrane No b-2 microglobulin Peptide antigen in a groove formed from a pair of a-helicies on a floor of anti-parallel b strands a2 & b2 domains have structural & amino acid sequence homology with Ig C domains Ig GENE SUPERFAMILY

MHC class II molecule structure Peptide a-chain b-chain Cleft is made of both a and b chains

View structures

Cleft geometry MHC class I MHC class II Peptide is held in the cleft by non-covalent forces

Cleft geometry a-chain a-chain Peptide b2-m Peptide b-chain MHC class I accommodate peptides of 8-10 amino acids MHC class II accommodate peptides of >13 amino acids

MHC-binding peptides Each human usually expresses: 3 types of MHC class I (A, B, C) and 3 types of MHC class II (DR, DP,DQ) The number of different T cell antigen receptors is estimated to be 1,000,000,000,000,000 Each of which may potentially recognise a different peptide antigen How can 6 invariant molecules have the capacity to bind to 1,000,000,000,000,000 different peptides?

A flexible binding site? A binding site that is flexible enough to bind any peptide? NO because: at the cell surface, such a binding site would be unable to allow a high enough binding affinity to form a trimolecular complex with the T cell antigen receptor prevent exchange of the peptide with others in the extracellular milieu

A flexible binding site? A binding site that is flexible at an early, intracellular stage of maturation Formed by folding the MHC molecules around the peptide. Venus fly trap Floppy Compact Allows a single type of MHC molecule to bind many different peptides bind peptides with high affinity form stable complexes at the cell surface Export only molecules that have captured a peptide to the cell surface

Peptides can be eluted from MHC molecules Purify stable MHCpeptide complexes Fractionate and microsequence peptides Acid elute peptides

Eluted peptides from MHC molecules have different sequences but contain motifs Peptides bound to a particular type of MHC class I molecule have conserved patterns of amino acids A common sequence in a peptide antigen that binds to an MHC molecule is called a MOTIF Amino acids common to many peptides tether the peptide to structural features of the MHC molecule ANCHOR RESIDUES Tethering amino acids need not be identical but must be related Y & F are aromatic V, L & I are hydrophobic Side chains of anchor residues bind into POCKETS in the MHC molecule N T Y Q R T R L V S Y F P E I H I K Y Q A V T T L S Y I P S A K I R G Y V Y Q Q L S I I N F E K L A P G N Y P A L Different types of MHC molecule bind peptides with different patterns of conserved amino acids C

Peptide binding pockets in MHC class I molecules Slices through MHC class I molecules, when viewed from above reveal deep, well conserved pockets

Anchor residues and T cell antigen receptor contact residues Cell surface MHC class I Sliced between a-helicies to reveal peptide MHC anchor residue side-chains point down T cell antigen receptor contact residue side-chains point up

MHC molecules can bind peptides of different length Arched peptide S Y I P S S A K I A Y K S I P S I MHC molecule MHC molecule Complementary anchor residues & pockets provide the broad specificity of a particular type of MHC molecule for peptides Peptide sequence between anchors can vary Number of amino acids between anchors can vary

Peptide antigen binding to MHC class II molecules Negatively charged Hydrophobic I S N Q L T L D S N T K Y F H K I P D N L F K S D G R I K Y T L N A T K Y G N M T E D H V N H L L Q N A G K F A I R P Y K K S N P I I R T V V F L L L L A Y K V P E T S L S T F D Y I A S G F R Q G G A S Q P P E V T V L T N S P V Y L R E P N V Y G Y T S Y Y F S W A E L T G H G A R T S T Y P T T D Y Anchor residues are not localised at the N and C termini Ends of the peptide are in extended conformation and may be trimmed Motifs are less clear than in class I-binding peptides Pockets are more permissive

Peptide binding pockets in MHC class II molecules Slices through MHC class II molecules, when viewed from above reveal shallow, poorly conserved pockets compared with those in MHC class I molecules

How can 6 invariant molecules have the capacity to bind to 1,000,000,000,000,000 different peptides with high affinity? Adopt a flexible floppy conformation until a peptide binds Fold around the peptide to increase stability of the complex Tether the peptide using a small number of anchor residues Allow different sequences between anchors and different lengths of peptide

MHC molecules are targets for immune evasion by pathogens Without T cells there is no effective immune response Ag specific T cells are activated by peptide/mhc complexes There is therefore strong selective pressure for pathogens to mutate genes encoding antigens so that they can evade the formation of peptide/mhc complexes The MHC has two strategies to prevent evasion by pathogens More than one type of MHC molecule in each individual Extensive differences in MHC molecules between individuals

Example: If MHC X was the only type of MHC molecule MHC XX Pathogen that evades MHC X Survival of individual threatened Population threatened with extinction

Example: If each individual could make two MHC molecules, MHC X and Y Pathogen that evades MHC X but has sequences that bind to MHC Y MHC XX MHC YY MHC XY Impact on the individual depends upon genotype Population survives

Example: If each individual could make two MHC molecules, MHC X and Y and the pathogen mutates Pathogen that evades MHC X but has sequences that bind to MHC Y.until it mutates to evade MHC Y MHC XX MHC YY MHC XY Survival of individual threatened Population threatened with extinction The number of types of MHC molecule can not be increased ad infinitum

Populations need to express variants of each type of MHC molecule Populations of microorganisms reproduce faster than humans Mutations that change MHC-binding antigens or MHC molecules can only be introduced to populations after reproduction The ability of microorganisms to mutate in order to evade MHC molecules will always outpace counter evasion measures that involve mutations in the MHC The number of types of MHC molecules are limited To counteract the superior flexibility of pathogens: Human populations possess many variants of each type of MHC molecule Variant MHC may not protect every individual from every pathogen. However, the existence of a large number of variants means that the population is prevented from extinction

Variant MHC molecules protect the population Pathogen that evades MHC X and Y but binds to the variant MHC X R and MHC Y R MHC XX MHC YY MHC XY XX XX R XY R YX R YY R YY X R X R From 2 MHC types and 2 variants. 10 different genotypes Y R Y R X R Y R XY MHC YY R MHC XX R Variants alleles - of each type of MHC gene encode proteins that increase the resistance of the population from rapidly mutating or newly encountered pathogens without increasing the number of types of MHC molecule

Molecular basis of MHC types and variants POLYGENISM Several MHC class I and class II genes encoding different types of MHC molecule with a range of peptide-binding specificities. POLYMORPHISM Variation >1% at a single genetic locus in a population of individuals MHC genes are the most polymorphic known The type and variant MHC molecules do not vary in the lifetime of the individual Diversity in MHC molecules exists at the population level This sharply contrasts diversity in T and B cell antigen receptors which are in a constant state of flux within the individual.

Simplified map of the HLA region DP DM LMP/TAP b a a b DQ b a b1 b3 DR b4 b5 a B C A MHC Class II MHC Class I Class III Polygeny CLASS I: 3 types HLA-A, HLA-B, HLA-C (sometimes called class Ia genes) CLASS II: 3 types HLA-DP HLA-DQ HLA-DR. 3 extra DRb genes in some individuals can allow 3 extra HLA-DR molecules Maximum of 9 types of antigen presenting molecule allow interaction with a wide range of peptides.

Detailed map of the HLA region http://www.anthonynolan.org.uk/hig/data.html September 2005 update

Map of the Human MHC from the Human Genome Project 3,838,986 bp 224 genes on chromosome 6 The MHC sequencing consortium Nature 401, 1999 http://webace.sanger.ac.uk/cgi-bin/ace/pic/6ace?name=mhc&class=map&click=400-1

Simplified map of the mouse MHC Chromosome 17 K M a b LMP/TAP A b a E b a D L Class I Class II Class III Class I Similar organisation to the human MHC except: one class I gene is translocated relative to human MHC 2 pairs of genes encoding class II molecules no alternative class II b chains

Other genes in the MHC MHC Class 1b genes Encoding MHC class I-like proteins that associate with b-2 microglobulin: HLA-G binds to CD94, an NK-cell receptor. Inhibits NK attack of foetus/ tumours HLA-E binds conserved leader peptides from HLA-A, B, C. Interacts with CD94 HLA-F function unknown MHC Class II genes Encoding several antigen processing genes: HLA-DMa and b, proteasome components LMP-2 & 7, peptide transporters TAP-1 & 2, HLA-DOa and DOb Many pseudogenes MHC Class III genes Encoding complement proteins C4A and C4B, C2 and FACTOR B TUMOUR NECROSIS FACTORS a AND b Immunologically irrelevant genes Genes encoding 21-hydroxylase, RNA Helicase, Caesin kinase Heat shock protein 70, Sialidase

Polymorphism in MHC Class I genes Variation >1% at a single genetic locus in a population of individuals In the human population, over 1300 MHC class I alleles have been identified - some are null alleles, synonyms or differ in regions outside the coding region 699 No of polymorphisms 396 1318 alleles (998 in October 2003) (657 in July 2000) 198 Class I 8 2 15 A B C E F G Data from www.anthonynolan.org.uk/hig/index.html September 2005

Polymorphism in MHC Class II genes Over 700 human MHC class II alleles have been identified - some are null alleles, synonyms or differ in regions outside the coding region No of polymorphisms 494 119 Class II 733 alleles (668 in October 2003) (492 in July 2000) 3 28 66 23 4 7 9 9 A B1 A1 B1 A1 B1 DR A B A B DQ DP DM DO Data from www.anthonynolan.org.uk/hig/index.html September 2005

Diversity of MHC Class I and II antigens Because so many MHC class I & II alleles are null, or contain synonymous mutations, the diversity of MHC molecules that can be identified by antibodies i.e. SEROLOGICALLY, is considerably fewer than that by DNA sequencing No of serologicallydefined antigens 62 Class I - ~100 antigens Class II - ~40 antigens (Figure hasn t changed since October 2003) 28 10 25 9 6 A B C DR DQ DP Data from www.anthonynolan.org.uk/hig/index.html September 2005

Most polymorphisms are point mutations 30 HLA-DPb allele sequences between Nucleotides 204 and 290 (amino acids 35-68) Polymorphic nucleotides encode amino acids associated with the peptide binding site E-A Y-F A-V Silent A-D A-E DPB1*01011 TAC GCG CGC TTC GAC AGC GAC GTG GGG GAG TTC CGG GCG GTG ACG GAG CTG GGG CGG CCT GCT GCG GAG TAC TGG AAC AGC CAG AAG GAC ATC CTG GAG GAG DPB1*01012 --- --- --- --- --- --- --- --- --A --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*02012 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -A- -A- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*02013 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -AC -A- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*0202 CT- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -AG --- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*0301 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -A- -A- --C --- --- --- --- --- --- --- C-- --- --- --- DPB1*0401 -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*0402 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -A- -A- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*0501 CT- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -AG --- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*0601 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -A- -A- --C --- --- --- --- --- --- --- C-- --- --- --- DPB1*0801 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -A- -A- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*0901 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -A- -A- --C --- --- --- --- --- --- --- --- --- --- --- DPB1*1001 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -A- -A- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*11011 --- --- --- --- --- --- --- --- --A --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- C-- --- --- --- DPB1*11012 --- --- --- --- --- --- --- --- --A --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- C-- --- --- --- DPB1*1301 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*1401 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -A- -A- --C --- --- --- --- --- --- --- C-- --- --- --- DPB1*1501 --- --- --- --- --- --- --- --- --A --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- C-- --- --- --- DPB1*1601 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -A- -A- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*1701 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -A- -A- --C --- --- --- --- --- --- --- --- --- --- --- DPB1*1801 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -A- -A- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*1901 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -AG --- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*20011 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -A- -A- --C --- --- --- --- --- --- --- C-- --- --- --- DPB1*20012 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -A- -A- --C --- --- --- --- --- --- --- C-- --- --- --- DPB1*2101 CT- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -AG --- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*2201 CT- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -AG --- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*2301 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*2401 -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -AG --- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*2501 -T- -T- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- -A- -A- --- --- --- --- --- --- --- --- C-- --- --- --- DPB1*26011 --- --- --- --- --- --- --- --- --A --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- DPB1*26012 --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- I-L

Polymorphism in the MHC affects peptide antigen binding MHC allele A MHC allele B Changes in the pockets, walls and floor of the peptide binding cleft alter peptide MHC interactions and determine which peptides bind. S Y I P S A K I R G Y V Y Q Q L MHC allele A MHC allele B Products of different MHC alleles bind a different repertoire of peptides

Replacement substitutions occur at a higher frequency than silent substitution Suggests that selective pressures may operate on MHC polymorphism Evolution of pathogens to evade MHC-mediated antigen presentation 60% of individuals in south east China & Papua New Guinea express HLA-A11 HLA-A11 binds an important peptide of Epstein Barr Virus Many EBV isolates from these areas have mutated this peptide so that it can not bind to HLA-A11 MHC molecules Evolution of the MHC to eliminate pathogens In west Africa where malaria is endemic HLA-B53 is commonly associated with recovery from a potentially lethal form of malaria

How diverse are MHC molecules in the population? IF each individual had 6 types of MHC the alleles of each MHC type were randomly distributed in the population any of the 1,200 alleles could be present with any other allele ~6 x 10 15 unique combinations In reality MHC alleles are NOT randomly distributed in the population Alleles segregate with lineage and race Group of alleles HLA-A1 HLA- A2 HLA- A3 HLA- A28 HLA- A36 Frequency (%) CAU AFR ASI 15.18 28.65 13.38 4.46 0.02 5.72 18.88 8.44 9.92 1.88 4.48 24.63 2.64 1.76 0.01

Diversity of MHC molecules in the individual DP DQ DR b a b a b1 a B C A Polygeny HAPLOTYPE 1 DP DQ DR b a b a b1 a B C A Variant alleles polymorphism HAPLOTYPE 2 DP DQ DR b a b a b1 a B C A Additional set of variant alleles on second chromosome MHC molecules are CODOMINANTLY expressed Two of each of the six types of MHC molecule are expressed Genes in the MHC are tightly LINKED and usually inherited in a unit called an MHC HAPLOTYPE

Inheritance of MHC haplotypes DP-1,2 DQ-3,4 DR-5,6 B-7,8 C-9,10 A-11,12 DP-9,8 DQ-7,6 DR-5,4 B-3,2 C-1,8 A-9,10 Parents DP DQ DR DP DQ DR X DP DQ DR DP DQ DR B C B C B C B C A A A A Children DP-1,9 DQ-3,7 DR-5,5 B-7,3 C-9,1 A-11,9 DP-1,8 DQ-3,6 DR-5,4 B-7,2 C-9,8 A-11,10 DP-2,8 DQ-4,6 DR-6,4 B-8,2 C-10,8 A-12,10 DP-2,9 DQ-4,7 DR-6,5 B-8,3 C-10,10 A-12,9 DP DQ DR DP DQ DR DP DQ DR DP DQ DR DP DQ DR DP DQ DR DP DQ DR DP DQ DR B C B C B C B C B C B C B C B C A A A A A A A A

Errors in the inheritance of haplotypes generate polymorphism in the MHC by gene conversion and recombination A B C A B C A B C Multiple distinct but closely related MHC genes A B C During meiosis chromosomes misalign A B C Chromosomes separate after meiosis DNA is exchanged between haplotypes GENE CONVERSION A B C RECOMBINATION between haplotypes In both mechanisms the type of MHC molecule remains the same, but a new allelic variant may be generated

A clinically relevant application of MHC genetics: Matching of transplant donors and recipients The biology, diversity and complexity of the MHC locus and its pattern of inheritance explains: The need to match the MHC of the recipient of a graft with the donor The difficulties faced in matching unrelated donors with recipients The ~20% chance of finding a match in siblings http://www-medlib.med.utah.edu/webpath/jpeg5/cv171 http://tpis.upmc.edu/tpis/images/c00005c

Molecular basis of transplant rejection TcR TcR TcR MHC A MHC B MHC C Normal peptide recognition Indirect peptide recognition Direct peptide recognition

Summary Transplant rejection occurs as a result of anti MHC immune responses The MHC was discovered using inbred strains of mice T cells recognise antigens in the context of MHC molecules MHC molecules bind to peptide antigens The structure of MHC molecules is directly related to their function in antigen presentation Polymorphism and polygenism in the MHC protects the population from pathogens evading the immune system